Hong Kong is in the midst of a clutch of massively ramped up stocks; only for massive takeunders to unfold as controlling shareholders exit.
Despite repeated messages to the HKEx, its responses have consistently been: “the subject matter is outside our power and scope of regulation. Therefore we will not take any further action“.
Non-Surgical medical aesthetic treatment play Fameglow (3774 HK) is currently suspended pursuant to the Takeovers Code. Fameglow is up 17x/116x (!) in the past one/five years. Expect another takeunder.
Fameglow (3774 HK): Expect (Another) Takeunder
Keep reading with a 7-day free trial
Subscribe to Hong Kong/China M&A/Events to keep reading this post and get 7 days of free access to the full post archives.